On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes

Published:2022-11-02 Issue:2 Volume:22 Page:284-299
ISSN:1539-1604
Container-title:Pharmaceutical Statistics
language:en
Short-container-title:Pharmaceutical Statistics

Author:

De Backer Mickaël¹^ORCID,Legrand Catherine¹,Péron Julien²³⁴,Lambert Alexandre⁵,Buyse Marc⁶⁷

Affiliation:

1. ISBA/LIDAM, UCLouvain Louvain‐la‐Neuve Belgium

2. CNRS, UMR 5558, Laboratoire de Biométrie et Biologie Evolutive, Equipe Biostatistique‐Santé Université Lyon 1 Villeurbanne France

3. Service de Biostatistique et Bioinformatique Hospices Civils de Lyon Lyon France

4. Oncology department Hospices Civils de Lyon Lyon France

5. Global Biometrics and Data Sciences, Bristol‐Myers Squibb Braine‐l'Alleud Belgium

6. International Drug Development Institute (IDDI) Louvain‐la‐Neuve Belgium

7. Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I‐BioStat) Hasselt University Diepenbeek Belgium

Funder

Walloon Region

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pst.2271

Reference29 articles.

1. Generalized pairwise comparisons of prioritized outcomes in the two-sample problem

2. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities

3. An extension of generalized pairwise comparisons for prioritized outcomes in the presence of censoring

4. Reformulating the hazard ratio to enhance communication with clinical investigators

5. On the win-ratio statistic in clinical trials with multiple types of event

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Restricted Net Treatment Benefit in oncology;Journal of Clinical Epidemiology;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3